Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Neurology Drugs Market Research Reports

Titlepublishedprice

United States Narcolepsy Drug Market by Manufacturers, States, Type and Application, Forecast to 2022

By Global Info Research
"...... of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same nu......"
04-May-2017$4480

Global Migraine Drugs Market Research Report 2017

By QYResearch Group
"...... tion, revenue (million USD), market share and growth rate of Migraine Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southeast Asia - India Gl......"
26-Apr-2017$2900

Global Edaravone Market Research Report 2017

By QYResearch Group
"...... revenue (million USD), market share and growth rate of Edaravone in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southeast Asia - India Glob......"
29-Mar-2017$2900

Global Narcolepsy Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

By Global Info Research
"...... of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same nu......"
28-Mar-2017$3480

Neurodegenerative Disorders Drug Development Pipeline Review, 2017

By GBI Research
"...... es symptoms such as motor impairment, memory loss and declining cognitive ability. Neurodegenerative disorders cannot currently be cured, and treatment is aimed at managing the disease indication in order to reduce the severity of symptoms and slow p......"
21-Mar-2017$3995

Global Carbamazepine (CBZ) Market Outlook 2017-2022

By Gen Consulting
"...... renia along with other medications and as a second line agent in bipolar disorder. This report provides detailed analysis of worldwide markets for Carbamazepine (CBZ) from 2011-2016, and provides extensive market forecasts (2016-2021) by......"
10-Mar-2017$2800

China Neuromyelitis Optica Drug Market Research Report 2017

By QYResearch Group
"...... enue and market share for each manufacturer, covering - Pfizer? - Fresenius? - TEVA? - Sandoz? - Intas - Gyjtrs? - Nang Kuang - Tianjin Kingyork - Baxter? - CSL? - Grifols?......"
13-Jan-2017$3200

Europe Neuromyelitis Optica Drug Market Report 2017

By QYResearch Group
"...... nd Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer? - Fresenius? - TEVA? - Sandoz? - Intas - Gyjtrs?......"
12-Jan-2017$3900

Global Myasthenia Gravis Drugs Market 2017-2021

By Technavio
"...... ecast period. For instance, Alexion Pharmaceuticals is currently developing a monoclonal antibody, Soliris, for the treatment of myasthenia gravis. Once launched around end 2017 or beginning of 2018, this drug is expected to be the blockbuster drug f......"
12-Jan-2017$3500

Relpax -Drug Insights, 2017

By Delve Insight
"...... the Relpax sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Relpax, patents information and exclusivity data, route of synthesis, competitive landscape,......"
01-Jan-2017$1000

Avail upto 25% Discount on below Publisher Reports.